HMG-CoA reductase inhibitor treatment in renal insufficiency

被引:7
作者
Wanner, C
机构
关键词
D O I
10.1093/oxfordjournals.ndt.a027076
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
引用
收藏
页码:1951 / 1952
页数:2
相关论文
共 5 条
[1]  
ECKARDT H, 1992, TREATMENT OF SEVERE DYSLIPOPROTEINEMIA IN THE PREVENTION OF CORONARY HEART DISEASE 3, P292
[2]   The hemodialysis (HEMO) study: Rationale for selection of interventions [J].
Eknoyan, G ;
Levey, AS ;
Beck, GJ ;
Agodoa, LY ;
Daugirdas, JT ;
Kusek, JW ;
Levin, NW ;
Schulman, G .
SEMINARS IN DIALYSIS, 1996, 9 (01) :24-33
[3]   LIPID-LOWERING THERAPY IN PATIENTS WITH RENAL-DISEASE [J].
MASSY, ZA ;
MA, JZ ;
LOUIS, TA ;
KASISKE, BL .
KIDNEY INTERNATIONAL, 1995, 48 (01) :188-198
[4]  
WANNER C, 1994, CLIN NEPHROL, V41, P138
[5]   EFFECTS OF HMG-COA REDUCTASE INHIBITORS IN HYPERCHOLESTEROLEMIC PATIENTS ON HEMODIALYSIS [J].
WANNER, C ;
HORL, WH ;
LULEY, CH ;
WIELAND, H .
KIDNEY INTERNATIONAL, 1991, 39 (04) :754-760